株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

細胞拡大市場:製品別(試薬、培地、フローサイトメトリ、遠心分離、バイオリアクター)、細胞タイプ別(ヒト、動物)、用途別(再生医療、幹細胞研究、癌・セルベース研究)、エンドユーザー別、地域別:2024年までの予測

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, & Region-Global Forecast to 2024

発行 MarketsandMarkets 商品コード 318042
出版日 ページ情報 英文 172 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
細胞拡大市場:製品別(試薬、培地、フローサイトメトリ、遠心分離、バイオリアクター)、細胞タイプ別(ヒト、動物)、用途別(再生医療、幹細胞研究、癌・セルベース研究)、エンドユーザー別、地域別:2024年までの予測 Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, & Region-Global Forecast to 2024
出版日: 2019年04月24日 ページ情報: 英文 172 Pages
概要

世界の細胞拡大市場は、2019年の127億米ドルから2024年末までに260億米ドルに達し、CAGR15.4%となると予測されています。世界的な癌の罹患率上昇、セルベース治療に対する認知度向上、研究に対する政府の支援などが市場の成長を支えています。

当レポートでは、世界の細胞拡大市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

318042_4.1 CELL EXPANSION MARKET MARKET OVERVIEW_FIGURE 14

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会

第6章 製品別市場

  • イントロダクション
  • 消耗品
    • 培地
    • 試薬
    • 血清
    • 使い捨て品
  • 計器
    • 細胞拡大支援装置
    • バイオリアクター
    • 自動システム

第7章 細胞タイプ別市場

  • イントロダクション
  • ヒトの細胞
  • 動物の細胞

第8章 用途別市場

  • イントロダクション
  • 再生医療と幹細胞研究
  • 癌とセルベース研究
  • その他

第9章 エンドユーザー別市場

  • イントロダクション
  • バイオテクノロジー企業、製薬会社
  • 研究機関
  • セルバンク
  • その他

第10章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第11章 競合動向

  • 概要
  • 市場シェア分析
  • 競合シナリオ
  • 競合リーダーシップマッピング

第12章 企業プロファイル

第13章 付録

図表

図表

LIST OF TABLES

  • TABLE 1: GLOBAL PREVALENCE OF DIABETES, BY REGION (MILLION), 2000 VS. 2030
  • TABLE 2: RISING INCIDENCE OF CANCER, BY TYPE (MILLION)
  • TABLE 3: GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008-2016
  • TABLE 4: R&D EXPENDITURE BY PHARMACEUTICAL COMPANIES, 2016 VS. 2017
  • TABLE 5: RISING REGULATORY APPROVALS FOR GMP TO BOOST THE MARKET
  • TABLE 6: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 7: CELL EXPANSION CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 9: CELL EXPANSION CONSUMABLES MARKET FOR MEDIA, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: CELL EXPANSION CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: CELL EXPANSION CONSUMABLES MARKET FOR SERA, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: CELL EXPANSION DISPOSABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 14: TISSUE CULTURE FLASKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: BIOREACTOR ACCESSORIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: OTHER DISPOSABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: CELL EXPANSION INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 19: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 20: FLOW CYTOMETERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: CENTRIFUGES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: CELL COUNTERS & HEMOCYTOMETERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 25: MICROCARRIER BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 27: MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: SUSPENSION-BASED ANCHORAGE-INDEPENDENT BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: PERFUSION/HOLLOW FIBER BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 32: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33: STEM CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 34: ADULT STEM CELLS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: INDUCED PLURIPOTENT STEM CELLS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: ESCS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: DIFFERENTIATED CELLS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: ANIMAL CELLS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 40: CELL EXPANSION MARKET FOR REGENERATIVE MEDICINE AND STEM CELL RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: CELL EXPANSION MARKET FOR CANCER AND CELL-BASED RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 44: CELL EXPANSION MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: CELL EXPANSION MARKET FOR RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46: CELL EXPANSION MARKET FOR CELL BANKS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: CELL EXPANSION MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48: CELL EXPANSION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 49: NORTH AMERICA: CELL EXPANSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: NORTH AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 53: NORTH AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: NORTH AMERICA: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: NORTH AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 56: NORTH AMERICA: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 57: US: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 58: US: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: US: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: US: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 61: US: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: US: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 63: US: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 64: CANADA: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 65: CANADA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: CANADA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 67: CANADA: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 68: CANADA: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: CANADA: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 70: CANADA: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 71: EUROPE: CELL EXPANSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 72: EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 73: EUROPE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: EUROPE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 75: EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 76: EUROPE: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 77: EUROPE: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 78: EUROPE: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 79: GERMANY: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 80: GERMANY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 81: GERMANY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: GERMANY: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: GERMANY: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: GERMANY: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 85: GERMANY: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 86: FRANCE: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 87: FRANCE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 88: FRANCE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 89: FRANCE: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: FRANCE: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: FRANCE: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 92: FRANCE: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 93: UK: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 94: UK: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: UK: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: UK: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: UK: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: UK: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 99: UK: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 100: ITALY: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 101: ITALY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: ITALY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: ITALY: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: ITALY: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105: ITALY: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 106: ITALY: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 107: SPAIN: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 108: SPAIN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: SPAIN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: SPAIN: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 111: SPAIN: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: SPAIN: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 113: SPAIN: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 114: ROE: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 115: ROE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 116: ROE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 117: ROE: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 118: ROE: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 119: ROE: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 120: ROE: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 121: ASIA PACIFIC: CELL EXPANSION MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 122: ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 123: ASIA PACIFIC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 124: ASIA PACIFIC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125: ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 126: ASIA PACIFIC: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 128: ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 129: JAPAN: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 130: JAPAN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 131: JAPAN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 132: JAPAN: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 133: JAPAN: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 134: JAPAN: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 135: JAPAN: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 136: CHINA: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 137: CHINA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 138: CHINA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 139: CHINA: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 140: CHINA: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141: CHINA: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 142: CHINA: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 143: INDIA: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 144: INDIA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 145: INDIA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 146: INDIA: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 147: INDIA: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 148: INDIA: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 149: INDIA: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 150: SINGAPORE: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 151: SINGAPORE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 152: SINGAPORE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 153: SINGAPORE: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 154: SINGAPORE: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 155: SINGAPORE: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 156: SINGAPORE: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 157: SOUTH KOREA: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 158: SOUTH KOREA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 159: SOUTH KOREA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 160: SOUTH KOREA: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 161: SOUTH KOREA: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 162: SOUTH KOREA: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 163: SOUTH KOREA: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 164: ROAPAC: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 165: ROAPAC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166: ROAPAC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 167: ROAPAC: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 168: ROAPAC: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 169: ROAPAC: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 170: ROAPAC: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 171: ROW: CELL EXPANSION MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 172: ROW: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 173: ROW: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 174: ROW: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 175: ROW: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 176: ROW: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 177: ROW: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 178: ROW: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 179: LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 180: LATIN AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 181: LATIN AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 182: LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 183: LATIN AMERICA: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 184: LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 185: LATIN AMERICA: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 186: MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 187: MIDDLE EAST & AFRICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 188: MIDDLE EAST & AFRICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 189: MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY CELL TYPE, 2017-2024 (USD MILLION)
  • TABLE 190: MIDDLE EAST & AFRICA: HUMAN CELLS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 191: MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 192: MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 CELL EXPANSION MARKET
  • FIGURE 2 CELL EXPANSION MARKET, BY REGION
  • FIGURE 3 CELL EXPANSION MARKET YEARS CONSIDERED FOR THE STUDY
  • FIGURE 4 RESEARCH DESIGN
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 CELL EXPANSION MARKET: BOTTOM-UP APPROACH
  • FIGURE 7 CELL EXPANSION MARKET: TOP-DOWN APPROACH
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 CELL EXPANSION MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10 CELL EXPANSION MARKET, BY CELL TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11 CELL EXPANSION MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 12 CELL EXPANSION MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 13 CELL EXPANSION MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND GOVERNMENT INVESTMENTS FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15 CELL EXPANSION CONSUMABLES TO DOMINATE THE MARKET IN NORTH AMERICA IN 2018
  • FIGURE 16 COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 17 CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE THE CELL EXPANSION PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19 HUMAN CELLS SEGMENT TO DOMINATE THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 20 REGENERATIVE MEDICINE AND STEM CELL RESEARCH SEGMENT TO DOMINATE THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 21 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE CELL EXPANSION MARKET IN 2024
  • FIGURE 23 NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT
  • FIGURE 24 NUMBER OF NEW CANCER CASES IN LATIN AMERICA, 2018-2035
  • FIGURE 25 KEY DEVELOPMENTS IN THE CELL EXPANSION MARKET FROM 2016 TO 2019
  • FIGURE 26 SHARE OF COMPANIES IN THE CELL EXPANSION MARKET, 2018
  • FIGURE 27 MNM DIVE-VENDOR COMPARISON MATRIX: CELL EXPANSION MARKET
  • FIGURE 28 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 30 TERUMO BCT: COMPANY SNAPSHOT (2017)
  • FIGURE 31 MERCK KGAA: COMPANY SNAPSHOT (2018)
  • FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2018) 151  
  • FIGURE 33 LONZA GROUP LTD: COMPANY SNAPSHOT (2018)
  • FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 35 CORNING, INC: COMPANY SNAPSHOT (2018)
目次
Product Code: BT 2850

"Cell expansion market to register a CAGR of 15.4% from 2019 to 2024"

The cell expansion market is projected to reach USD 26.0 Billion by 2024 from USD 12.7 Billion in 2019, at a CAGR of 15.4% during the forecast period. Growth in this market is mainly driven by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.

"Consumables accounted for the larger share of the cell expansion market in 2018"

On the basis of products, the cell expansion market is segmented into consumables and instruments. Consumables are segmented into reagents, media, sera, and disposables. The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. In 2018, consumables accounted for the largest share of the cell expansion products market owing to the constant requirement for new reagents among end users and rising investments for R&D on cell-based therapies.

"Human cells accounted for the largest share of the cell expansion market in 2018"

Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. These cells are used for therapeutic and research purposes. In 2018, the human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

"North America dominates the cell expansion market"

North America, which includes the US and Canada, accounted for the largest share of the cell expansion in 2018. The large share of this market segment can be attributed to the government funding for cancer research, increasing awareness regarding advanced treatment theories, and the strong presence of industry players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1: 70% , Tier 2: 20%, and Tier 3: 10%
  • By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
  • By Region: North America: 35%, Europe: 24%, Asia: 25%, and the RoW: 16%

The major players operating in this market are: Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (US), Miltenyi Biotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (US), and Corning, Inc. (US).

Research Coverage:

This report studies the cell expansion market based on product, cell type, application, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell expansion market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the cell expansion offered by the top 10 players in the market. The report analyzes the cell expansion market by product and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell expansion across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell expansion market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKETS COVERED
    • 1.2.2 COUNTRY COVERAGE
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 SECONDARY DATA
    • 2.1.1 KEY DATA FROM SECONDARY SOURCES
  • 2.2 PRIMARY DATA
    • 2.2.1 KEY DATA FROM PRIMARY SOURCES
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CELL EXPANSION MARKET: MARKET OVERVIEW
  • 4.2 NORTH AMERICA: CELL EXPANSION MARKET, BY PRODUCT (2018)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL EXPANSION MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of chronic diseases
      • 5.2.1.2 Government investments for cell-based research
      • 5.2.1.3 Growing focus on personalized medicine
      • 5.2.1.4 Increasing focus on R&D for cell-based therapies
      • 5.2.1.5 Increasing GMP certifications for cell therapy production facilities
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Ethical concerns regarding research in cell biology
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 3D cell expansion technology

6 CELL EXPANSION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 MEDIA
      • 6.2.1.1 Media segment to dominate the cell expansion consumables market
    • 6.2.2 REAGENTS
      • 6.2.2.1 Reagents segment to account for the second-largest share of the cell expansion consumables market
    • 6.2.3 SERA
      • 6.2.3.1 North America to dominate the cell expansion sera market
    • 6.2.4 DISPOSABLES
      • 6.2.4.1 Tissue culture flasks
        • 6.2.4.1.1 Tissue culture flasks segment accounted for the largest share of the disposables market
      • 6.2.4.2 Bioreactor accessories
        • 6.2.4.2.1 Bioreactor accessories segment accounted for the second-largest share of the disposables market
      • 6.2.4.3 Other disposables
  • 6.3 INSTRUMENTS
    • 6.3.1 CELL EXPANSION SUPPORTING EQUIPMENT
      • 6.3.1.1 Flow cytometers
        • 6.3.1.1.1 Product launches to drive the growth of this market segment
      • 6.3.1.2 Centrifuges
        • 6.3.1.2.1 Major players are focusing on launching new and advanced centrifuges in the market
      • 6.3.1.3 Cell counters & Hemocytometers
        • 6.3.1.3.1 Technological advancements supporting the growth of the cell counters & hemocytometers market
      • 6.3.1.4 Other supporting equipment
    • 6.3.2 BIOREACTORS
      • 6.3.2.1 Microcarrier bioreactors
        • 6.3.2.1.1 Microcarrier-based anchorage-dependent bioreactors
        • 6.3.2.1.1.1 Microcarrier-based anchorage-dependent bioreactors offer large-scale production
        • 6.3.2.1.2 Suspension-based anchorage-independent bioreactors
        • 6.3.2.1.2.1 North America is the largest market for suspension-based anchorage-independent bioreactors
      • 6.3.2.2 Perfusion/hollow fiber bioreactors
        • 6.3.2.2.1 Collaborations and product launches supporting the growth of this market segment
    • 6.3.3 AUTOMATED CELL EXPANSION SYSTEMS
      • 6.3.3.1 Technological advancements to drive the growth of this market segment

7 CELL EXPANSION MARKET, BY CELL TYPE

  • 7.1 INTRODUCTION
  • 7.2 HUMAN CELLS
    • 7.2.1 STEM CELLS
      • 7.2.1.1 Adult stem cells
        • 7.2.1.1.1 Adult stem cells segment accounts for the largest share of the human stem cells market, primarily due to increased government initiatives in cell-based research
      • 7.2.1.2 Induced pluripotent stem cells (iPSCs)
        • 7.2.1.2.1 iPSCs are sued in cell replacement therapies, drug screening, and tissue regeneration
      • 7.2.1.3 Embryonic stem cells (ESCs)
        • 7.2.1.3.1 Increasing private and public investments for stem cell research-major factor driving market growth
    • 7.2.2 DIFFERENTIATED CELLS
      • 7.2.2.1 Increasing prevalence of cancer is the major factor driving the growth of this market
  • 7.3 ANIMAL CELLS
    • 7.3.1 BIOPHARMACEUTICAL COMPANIES ARE THE MAJOR END USERS OF ANIMAL CELLS

8 CELL EXPANSION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 REGENERATIVE MEDICINE AND STEM CELL RESEARCH
    • 8.2.1 INCREASING GOVERNMENT FUNDING ON REGENERATIVE MEDICINE AND STEM CELL RESEARCH TO DRIVE MARKET GROWTH
  • 8.3 CANCER AND CELL-BASED RESEARCH
    • 8.3.1 INCREASING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH
  • 8.4 OTHER APPLICATIONS

9 CELL EXPANSION MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES
    • 9.2.1 INCREASING INVESTMENTS IN CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
  • 9.3 RESEARCH INSTITUTES
    • 9.3.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE THE MARKET FOR RESEARCH INSTITUTES
  • 9.4 CELL BANKS
    • 9.4.1 INCREASING AWARENESS AMONG PEOPLE ABOUT THE BENEFITS OF PRESERVING STEM CELLS TO DRIVE MARKET GROWTH
  • 9.5 OTHER END USERS

10 CELL EXPANSION MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 US to witness the highest growth in the North American cell expansion market due to the increasing government funding on cell-based research
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany is the fastest-growing market for cell expansion in Europe
    • 10.3.2 FRANCE
      • 10.3.2.1 Robust biotechnology infrastructure in the country to support market growth
    • 10.3.3 UK
      • 10.3.3.1 Government investments in stem cell research to drive the market for cell expansion in the UK
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell expansion products
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing funding from private and public organizations to aid market growth
    • 10.3.6 REST OF EUROPE (ROE)
  • 10.4 ASIA PACIFIC
    • 10.4.1 JAPAN
      • 10.4.1.1 Growing geriatric population in the country to drive market growth
    • 10.4.2 CHINA
      • 10.4.2.1 Government initiatives to promote stem cell research to play a major role in driving market growth
    • 10.4.3 INDIA
      • 10.4.3.1 Growing pharmaceutical and biotechnology industries-key growth driver for the cell expansion market in India
    • 10.4.4 SINGAPORE
      • 10.4.4.1 Presence of leading pharmaceutical companies is supporting the growth of the cell expansion market in the country
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Conferences and research activities on stem cells are supporting the growth of the cell expansion market in the country
    • 10.4.6 REST OF ASIA PACIFIC

  • 10.5 ROW
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Increasing incidence of cancer to drive the market for cell expansion
    • 10.5.2 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET SHARE ANALYSIS, 2018
  • 11.3 COMPETITIVE SCENARIO
    • 11.3.1 PRODUCT LAUNCHES AND APPROVALS, 2016-2019
    • 11.3.2 ACQUISITIONS, 2016-2019
    • 11.3.3 AGREEMENTS, 2016-2019
    • 11.3.4 EXPANSIONS, 2016-2019
  • 11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
    • 11.4.1 VENDOR INCLUSION CRITERIA
    • 11.4.2 VISIONARY LEADERS
    • 11.4.3 INNOVATORS
    • 11.4.4 DYNAMIC DIFFERENTIATORS
    • 11.4.5 EMERGING COMPANIES

12 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 12.1 THERMO FISHER SCIENTIFIC, INC.
  • 12.2 BECTON, DICKINSON AND COMPANY
  • 12.3 TERUMO BCT
  • 12.4 MERCK KGAA
  • 12.5 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION)
  • 12.6 MILTENYI BIOTEC
  • 12.7 LONZA GROUP LTD.
  • 12.8 STEMCELL TECHNOLOGIES, INC.
  • 12.9 GE HEALTHCARE
  • 12.10 CORNING INCORPORATED

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS OF INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS
Back to Top